4月10日,和铂医药正式宣布任命陈侑晨为首席财务官(CFO)。陈侑晨将常驻上海和中国香港两地,直接向公司创始人、董事长兼首席执行官王劲松博士汇报。这一人事变动引发市场广泛关注,被视为和铂医药强化财务管理和战略发展的重要举措。据悉,加入和铂医药前,陈侑晨曾担任临床阶段放射性制药初创公司担任首席财务官、瑞信中国投资银行及资本市场部副总裁、毕马威担任审计助理经理,拥有复旦大学法学学士学位及乔治城大学...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.